This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitiveintelligence (M/CI) vendors can best work together.
Ryan Tohill is currently an associate director of globalcompetitiveintelligence for dermatology and rheumatology at The Janssen Pharmaceutical Companies of Johnson & Johnson, based in Horsham, Pennsylvania. Tohill is not new to the world of medicine and pharmaceutical sciences. ArchIntel™ -.
A director of competitiveintelligence role is open at Moderna , one of the pharmaceutical companies that has developed a vaccine for COVID-19. The director will also assess the reliability of competitiveintelligence research findings to maintain high standards of accuracy, relevance and quality, Moderna noted.
Are you interested in a career in competitiveintelligence? The industry is constantly growing as organisations recognise the value of mapping the competitive landscape, and quantifying the threats and opportunities presented by rivals. Aqute Intelligence is always looking for new analysts to join our global team.
Volkan Gunduz is an associate director of competitiveintelligence for global oncology at Sanofi Genzyme, based in Cambridge, Massachusetts. However, he is not new to the pharmaceutical and health care industry. ArchIntel™ -. He later earned his doctorate in genetics from the Tufts University School of Medicine.
pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. This fierce competition is predicted to propel the U.S. ArchIntel™ -. These are some of the U.S.
“Globalpharmaceutical manufacturing industry will reach $673.6 Competitiveintelligence can help pharmaceutical companies secure drug approval from the Food and Drug Administration, according to Cipher President Peter Grimm. ArchIntel™ -. billion by 2027, growing by 12.5%
“The globalpharmaceutical manufacturing market is expected to garner growth at a noteworthy CAGR of 12.8% Bristol Myers Squibb , a biopharmaceutical company, is looking to hire an associate director of competitiveintelligence focused on hematology and oncology. ArchIntel™ -. from 2021 to 2030.”
“The globalpharmaceutical manufacturing market is expected to garner growth at a noteworthy CAGR of 12.8% LEO Pharma has put the word out that it is on the hunt for its next associate director for market research and competitiveintelligence for its operations in the United States. ArchIntel™ -. from 2021 to 2030.”
AbbVie, a science and health care company , has announced an opening for a full-time associate director of competitiveintelligence for immunology. The role is responsible for providing detailed and actionable intelligence about competitive forces in the current and future market, AbbVie said.
Anindita Niyogi is the director of global customer analytics and insights at Pfizer , one of the pharmaceutical companies that has developed a vaccine for the novel coronavirus disease. Before joining Pfizer, she spent seven years at AstraZeneca Pharmaceuticals , which has also developed a COVID-19 vaccine. ArchIntel™ -.
health care sector is seen to experience an unprecedented level of competition. Through all this, competitiveintelligence professionals will surely be pushed hard to generate much-needed insights. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis.
Citing Deloitte’s 2021 Global Human Capital Trends survey , the Insights team said organizational preparedness hinges on three inherently human concepts : purpose, potential and perspective. Pharmaceutical company AstraZeneca capitalized on the potential of its workforce to develop a COVID-19 vaccine.
The globalpharmaceutical industry in itself is highly competitive, driven by a constant need to innovate and discover new drugs. Producing and manufacturing drugs and medical devices is an expensive business to be a part of.
And our 2023 Global Consumer Insight Analytics survey report showcases how marketers across various industries leverage consumer research to promote brand recognition and drive business growth. Be sure to check out our 2023 Global Consumer Insights Analytics Report. We highlight some key points from the report below!
“The globalpharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 PharmaEssentia has posted a job opening on LinkedIn for a full-time business intelligence and analytics director. The role also has competitiveintelligence functions. ArchIntel™ -. between 2020 and 2027.”
In light of the opportunities and challenges faced by the A&D industry this year, knowing how competitors intend to adapt is strategically important, making the role of competitiveintelligence executives critical. Stefanie Kowitt is the head of Lockheed Martin’s capture excellence and competitiveintelligence team.
Global Health Supply Chain Program-Procurement and Supply Management ( GHSC-PSM ) – This program coordinates the procurement and delivery of lifesaving health commodities in more than two dozen countries. USAID is planning to compete the next iteration of this work, NextGen Global Health Supply Chain, this year.
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. How Pharmaceutical Market Research Is Changing Historically, market research methods in the pharmaceutical industry involved relying on historical datasets and manually searching for information from incomplete and disparate sources.
Interestingly, the pharmaceutical and medicine manufacturing subsector has seen the highest job growth numbers recently, even overtaking the aerospace products and parts subsector. In such an environment, competitiveintelligence professionals must work extra hard to deliver desperately-needed insights.
Nowhere is competitive benchmarking more important than in the globalpharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
Nowhere is competitive benchmarking more important than in the globalpharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
How many organisations predicted the global pandemic? Cultural intelligence (C) From SWOT to TOWS. The global pandemic has created an unprecedented external threat which has made many internal strengths irrelevant. Several leading pharmaceutical companies working with flawed assumptions were operating with serious blind-spots.
Without a doubt, each company in the crucial sector will press their competitiveintelligence executives for the insights needed to enhance competitiveness amid uncertain times. Beth Kinzer Global Director UPS. Executive Profile: Beth Kinzer, Global Director of Corporate Strategy at UPS.
To survive in today’s fast-moving and always-evolving market landscape, every business needs competitiveintelligence (CI)—comprehensive knowledge about your competitors and how your company stacks up. CI allows you to track competitor behavior and glean the insights you need to create competitive advantages.
But the voluntary shutdown of global economies has forced an accelerated adoption of these trends, presenting solid opportunities for these disruptors to gain traction as consumers become accustomed to the benefits of managing and receiving their healthcare online. How Fuld + Company works with our clients.
Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors. SMX also provides C5ISR services globally across each service branch and multiple Combatant Commands (COCOMs). Datastrong also brought new federal clients within the U.S. Department of Justice (DOJ) and U.S.
November 26, 2019 — Fuld + Company, a globalcompetitive strategy consultancy, today announced the recent appointment of Michael Ratcliffe as a Senior Director and Head of the Health & Life Sciences Practice. Fuld + Company is celebrating its 40 th year in business and is a pioneer in competitive strategy consulting.
In this role, Brad will advise our teams and clients from the Health and Life Sciences industries, and promote our portfolio of solutions, including market and business research, competitiveintelligence, thought leadership, data analytics, strategic insights, and shared services. About Fuld & Company. www.fuld.com.
When competing for peace during transitions “several factors impact each AO, such as competing global and regional influences; urbanization; failed, failing, or recovering governance apparatus; non-state actors; and other state actors; degraded economic conditions; pandemics; and other health crises” (FM 3-47, Civil Affairs Operations, 2021).
AlphaSense, on the other hand, ensures that our clients have unfettered access to broker reports with our Wall Street Insights ® offering—a leading collection of equity research covering global sector themes, industries, and companies from 1,000+ sell-side and independent firms—indexed, searchable, and all in one place.
Competitor monitoring transcends industries and equips every kind of business—from startups to global corporations—with the intelligence they need to navigate complex markets and outmaneuver their competition.
Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space.
Value: To date, GLG serves leading technology, life science, and industrial companies, including 40% of the Fortune 100 and seven of the top 10 global technology companies; leading investment and financial firms; top professional services firms; and hundreds of nonprofits and social entrepreneurs around the world.
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content